Promedior

New class of pentraxin therapeutics to treat rare fibrotic diseases, including: idiopathic pulmonary fibrosis (IPF), myelofibrosis, and fibrovascular....

Get a Demo and See the Full Profile

Get a demo today to see profiles of Promedior plus 5979 other startups.

Learn More About Promedior

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More